Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc207_6, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 6 input genes in category / 15 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0001601 peptide YY receptor activity 2.970E-15 4.454E-14 1.478E-13 4.454E-14 4 4
2 GO:0004983 neuropeptide Y receptor activity 6.233E-13 4.675E-12 1.551E-11 9.350E-12 4 10
3 GO:0001602 pancreatic polypeptide receptor activity 7.387E-11 3.693E-10 1.226E-9 1.108E-9 3 4
4 GO:0008188 neuropeptide receptor activity 4.829E-10 1.811E-9 6.008E-9 7.243E-9 4 46
5 GO:0008528 G protein-coupled peptide receptor activity 3.549E-8 9.714E-8 3.223E-7 5.323E-7 4 132
6 GO:0001653 peptide receptor activity 3.886E-8 9.714E-8 3.223E-7 5.828E-7 4 135
7 GO:0005184 neuropeptide hormone activity 4.529E-5 9.705E-5 3.220E-4 6.793E-4 2 33
8 GO:0005246 calcium channel regulator activity 6.026E-5 1.130E-4 3.749E-4 9.038E-4 2 38
9 GO:0031841 neuropeptide Y receptor binding 3.215E-4 5.359E-4 1.778E-3 4.823E-3 1 1
10 GO:0005179 hormone activity 6.456E-4 9.685E-4 3.214E-3 9.685E-3 2 124
11 GO:0016247 channel regulator activity 8.103E-4 1.105E-3 3.666E-3 1.215E-2 2 139
12 GO:0001664 G protein-coupled receptor binding 3.144E-3 3.929E-3 1.304E-2 4.715E-2 2 276
13 GO:0071855 neuropeptide receptor binding 9.927E-3 1.145E-2 3.801E-2
1.489E-1
 1 31
Show 8 more annotations

2: GO: Biological Process [Display Chart] 6 input genes in category / 235 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0007218 neuropeptide signaling pathway 3.122E-14 7.336E-12 4.430E-11 7.336E-12 6 107
2 GO:0007631 feeding behavior 1.298E-13 1.525E-11 9.207E-11 3.049E-11 6 135
3 GO:0003151 outflow tract morphogenesis 9.659E-7 7.566E-5 4.569E-4 2.270E-4 3 69
4 GO:0003214 cardiac left ventricle morphogenesis 1.174E-5 6.233E-4 3.764E-3 2.759E-3 2 17
5 GO:0007586 digestion 1.625E-5 6.233E-4 3.764E-3 3.820E-3 3 176
6 GO:0032095 regulation of response to food 1.812E-5 6.233E-4 3.764E-3 4.257E-3 2 21
7 GO:0007187 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger 1.857E-5 6.233E-4 3.764E-3 4.363E-3 3 184
8 GO:0032098 regulation of appetite 2.802E-5 8.230E-4 4.970E-3 6.584E-3 2 26
9 GO:0051048 negative regulation of secretion 3.809E-5 9.946E-4 6.007E-3 8.952E-3 3 234
10 GO:0003007 heart morphogenesis 4.752E-5 1.117E-3 6.743E-3 1.117E-2 3 252
11 GO:0032094 response to food 7.054E-5 1.450E-3 8.758E-3 1.658E-2 2 41
12 GO:0042755 eating behavior 7.406E-5 1.450E-3 8.758E-3 1.740E-2 2 42
13 GO:0003208 cardiac ventricle morphogenesis 2.189E-4 3.822E-3 2.308E-2
5.144E-2
 2 72
14 GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway 2.313E-4 3.822E-3 2.308E-2
5.434E-2
 2 74
15 GO:0050805 negative regulation of synaptic transmission 2.439E-4 3.822E-3 2.308E-2
5.733E-2
 2 76
16 GO:0051952 regulation of amine transport 3.653E-4 5.365E-3 3.240E-2
8.584E-2
 2 93
17 GO:0015837 amine transport 4.222E-4 5.837E-3 3.525E-2
9.922E-2
 2 100
18 GO:0006939 smooth muscle contraction 5.483E-4 7.158E-3 4.323E-2
1.289E-1
 2 114
19 GO:0003206 cardiac chamber morphogenesis 6.174E-4 7.636E-3 4.612E-2
1.451E-1
 2 121
20 GO:0003231 cardiac ventricle development 6.798E-4 7.988E-3 4.824E-2
1.598E-1
 2 127
21 GO:0019233 sensory perception of pain 7.677E-4 8.590E-3
5.188E-2
1.804E-1
 2 135
22 GO:0060112 generation of ovulation cycle rhythm 9.663E-4 1.014E-2
6.126E-2
2.271E-1
 1 3
23 GO:0007270 neuron-neuron synaptic transmission 9.971E-4 1.014E-2
6.126E-2
2.343E-1
 2 154
24 GO:0007188 adenylate cyclase-modulating G protein-coupled receptor signaling pathway 1.036E-3 1.014E-2
6.126E-2
2.435E-1
 2 157
25 GO:0044070 regulation of anion transport 1.157E-3 1.081E-2
6.529E-2
2.719E-1
 2 166
26 GO:0003205 cardiac chamber development 1.241E-3 1.081E-2
6.529E-2
2.918E-1
 2 172
27 GO:0032097 positive regulation of response to food 1.288E-3 1.081E-2
6.529E-2
3.027E-1
 1 4
28 GO:0032100 positive regulation of appetite 1.288E-3 1.081E-2
6.529E-2
3.027E-1
 1 4
29 GO:0032107 regulation of response to nutrient levels 1.419E-3 1.111E-2
6.712E-2
3.334E-1
 2 184
30 GO:0032104 regulation of response to extracellular stimulus 1.419E-3 1.111E-2
6.712E-2
3.334E-1
 2 184
31 GO:0008217 regulation of blood pressure 1.624E-3 1.231E-2
7.434E-2
3.816E-1
 2 197
32 GO:1903531 negative regulation of secretion by cell 1.791E-3 1.315E-2
7.942E-2
4.209E-1
 2 207
33 GO:0002865 negative regulation of acute inflammatory response to antigenic stimulus 1.932E-3 1.376E-2
8.308E-2
4.540E-1
 1 6
34 GO:0007626 locomotory behavior 2.281E-3 1.577E-2
9.521E-2
5.360E-1
 2 234
35 GO:0032229 negative regulation of synaptic transmission, GABAergic 2.575E-3 1.729E-2
1.044E-1
6.051E-1
 1 8
36 GO:0014050 negative regulation of glutamate secretion 2.897E-3 1.840E-2
1.111E-1
6.807E-1
 1 9
37 GO:0046010 positive regulation of circadian sleep/wake cycle, non-REM sleep 2.897E-3 1.840E-2
1.111E-1
6.807E-1
 1 9
38 GO:0090394 negative regulation of excitatory postsynaptic potential 3.218E-3 1.891E-2
1.142E-1
7.562E-1
 1 10
39 GO:0019732 antifungal humoral response 3.218E-3 1.891E-2
1.142E-1
7.562E-1
 1 10
40 GO:0030432 peristalsis 3.218E-3 1.891E-2
1.142E-1
7.562E-1
 1 10
41 GO:0008343 adult feeding behavior 3.539E-3 1.980E-2
1.196E-1
8.317E-1
 1 11
42 GO:0051967 negative regulation of synaptic transmission, glutamatergic 3.539E-3 1.980E-2
1.196E-1
8.317E-1
 1 11
43 GO:0033603 positive regulation of dopamine secretion 3.860E-3 2.035E-2
1.229E-1
9.072E-1
 1 12
44 GO:0051480 regulation of cytosolic calcium ion concentration 3.864E-3 2.035E-2
1.229E-1
9.081E-1
 2 306
45 GO:0032102 negative regulation of response to external stimulus 4.141E-3 2.035E-2
1.229E-1
9.731E-1
 2 317
46 GO:2000252 negative regulation of feeding behavior 4.182E-3 2.035E-2
1.229E-1
9.827E-1
 1 13
47 GO:0045938 positive regulation of circadian sleep/wake cycle, sleep 4.182E-3 2.035E-2
1.229E-1
9.827E-1
 1 13
48 GO:0032103 positive regulation of response to external stimulus 4.427E-3 2.035E-2
1.229E-1
1.000E0
 2 328
49 GO:0045188 regulation of circadian sleep/wake cycle, non-REM sleep 4.503E-3 2.035E-2
1.229E-1
1.000E0
 1 14
50 GO:0032096 negative regulation of response to food 4.503E-3 2.035E-2
1.229E-1
1.000E0
 1 14
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 6 input genes in category / 9 annotations before applied cutoff / 19061 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0098793 presynapse 4.564E-3 4.108E-2
1.162E-1
 4.108E-2 2 341

4: Human Phenotype [Display Chart] 0 input genes in category / 0 annotations before applied cutoff / 4707 genes in category

No results to display

5: Mouse Phenotype [Display Chart] 5 input genes in category / 329 annotations before applied cutoff / 10355 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0020130 abnormal total fat pad weight 1.165E-9 3.834E-7 2.444E-6 3.834E-7 4 42
2 MP:0011117 abnormal susceptibility to weight gain 1.120E-8 1.842E-6 1.174E-5 3.683E-6 5 268
3 MP:0005334 abnormal fat pad morphology 2.043E-8 2.145E-6 1.367E-5 6.721E-6 5 302
4 MP:0002970 abnormal white adipose tissue morphology 2.607E-8 2.145E-6 1.367E-5 8.578E-6 5 317
5 MP:0005455 increased susceptibility to weight gain 8.792E-8 5.785E-6 3.688E-5 2.892E-5 4 121
6 MP:0014145 increased white adipose tissue mass 5.595E-7 3.068E-5 1.956E-4 1.841E-4 2 3
7 MP:0010878 increased trabecular bone volume 9.288E-7 3.901E-5 2.487E-4 3.056E-4 3 48
8 MP:0000008 increased white adipose tissue amount 9.893E-7 3.901E-5 2.487E-4 3.255E-4 3 49
9 MP:0005667 abnormal circulating leptin level 1.067E-6 3.901E-5 2.487E-4 3.511E-4 4 225
10 MP:0001781 abnormal white adipose tissue amount 1.501E-6 4.939E-5 3.148E-4 4.939E-4 4 245
11 MP:0000010 abnormal abdominal fat pad morphology 1.707E-6 5.106E-5 3.255E-4 5.617E-4 4 253
12 MP:0001433 polyphagia 3.192E-6 8.543E-5 5.446E-4 1.050E-3 3 72
13 MP:0000130 abnormal trabecular bone morphology 3.375E-6 8.543E-5 5.446E-4 1.111E-3 4 300
14 MP:0010875 increased bone volume 4.228E-6 9.935E-5 6.333E-4 1.391E-3 3 79
15 MP:0004890 decreased energy expenditure 4.732E-6 1.038E-4 6.617E-4 1.557E-3 3 82
16 MP:0005345 abnormal circulating corticosterone level 5.859E-6 1.123E-4 7.157E-4 1.928E-3 3 88
17 MP:0001260 increased body weight 6.247E-6 1.123E-4 7.157E-4 2.055E-3 4 350
18 MP:0012323 increased total tissue mass 6.247E-6 1.123E-4 7.157E-4 2.055E-3 4 350
19 MP:0003366 abnormal circulating glucocorticoid level 6.483E-6 1.123E-4 7.157E-4 2.133E-3 3 91
20 MP:0003963 abnormal corticosterone level 7.620E-6 1.253E-4 7.990E-4 2.507E-3 3 96
21 MP:0014146 decreased white adipose tissue mass 8.381E-6 1.313E-4 8.371E-4 2.757E-3 2 10
22 MP:0010877 abnormal trabecular bone volume 9.700E-6 1.348E-4 8.592E-4 3.191E-3 3 104
23 MP:0001264 increased body size 9.915E-6 1.348E-4 8.592E-4 3.262E-3 4 393
24 MP:0014144 abnormal white adipose tissue mass 1.024E-5 1.348E-4 8.592E-4 3.370E-3 2 11
25 MP:0004702 increased circulating insulin-like growth factor I level 1.024E-5 1.348E-4 8.592E-4 3.370E-3 2 11
26 MP:0001261 obese 1.087E-5 1.375E-4 8.767E-4 3.576E-3 3 108
27 MP:0005669 increased circulating leptin level 1.647E-5 2.007E-4 1.279E-3 5.419E-3 3 124
28 MP:0005449 abnormal food intake 2.055E-5 2.415E-4 1.539E-3 6.762E-3 4 472
29 MP:0011957 decreased compensatory feeding amount 2.232E-5 2.533E-4 1.615E-3 7.345E-3 2 16
30 MP:0009304 increased retroperitoneal fat pad weight 2.845E-5 3.120E-4 1.989E-3 9.361E-3 2 18
31 MP:0011939 increased food intake 3.811E-5 3.891E-4 2.481E-3 1.254E-2 3 164
32 MP:0008908 increased total fat pad weight 3.903E-5 3.891E-4 2.481E-3 1.284E-2 2 21
33 MP:0011956 abnormal compensatory feeding amount 3.903E-5 3.891E-4 2.481E-3 1.284E-2 2 21
34 MP:0014142 increased body fat mass 4.292E-5 4.060E-4 2.588E-3 1.412E-2 2 22
35 MP:0010874 abnormal bone volume 4.319E-5 4.060E-4 2.588E-3 1.421E-2 3 171
36 MP:0008907 decreased total fat pad weight 4.700E-5 4.296E-4 2.738E-3 1.546E-2 2 23
37 MP:0005288 abnormal oxygen consumption 6.107E-5 5.430E-4 3.461E-3 2.009E-2 3 192
38 MP:0001425 abnormal alcohol consumption 9.199E-5 7.964E-4 5.077E-3 3.026E-2 2 32
39 MP:0002079 increased circulating insulin level 9.673E-5 8.053E-4 5.133E-3 3.182E-2 3 224
40 MP:0004279 abnormal rostral migratory stream morphology 9.790E-5 8.053E-4 5.133E-3 3.221E-2 2 33
41 MP:0010024 increased total body fat amount 1.033E-4 8.290E-4 5.285E-3 3.399E-2 3 229
42 MP:0006092 abnormal olfactory sensory neuron morphology 1.168E-4 9.145E-4 5.830E-3 3.841E-2 2 36
43 MP:0004275 abnormal postnatal subventricular zone morphology 1.234E-4 9.441E-4 6.019E-3 4.060E-2 2 37
44 MP:0005450 abnormal energy expenditure 1.358E-4 1.015E-3 6.471E-3 4.466E-2 3 251
45 MP:0001001 abnormal chemoreceptor morphology 1.444E-4 1.054E-3 6.717E-3 4.752E-2 2 40
46 MP:0005448 abnormal energy homeostasis 1.473E-4 1.054E-3 6.717E-3 4.847E-2 3 258
47 MP:0009285 increased gonadal fat pad weight 1.518E-4 1.063E-3 6.774E-3 4.995E-2 2 41
48 MP:0005337 abnormal retroperitoneal fat pad morphology 1.750E-4 1.200E-3 7.648E-3
5.759E-2
 2 44
49 MP:0009347 increased trabecular bone thickness 2.174E-4 1.460E-3 9.305E-3
7.152E-2
 2 49
50 MP:0009745 abnormal behavioral response to xenobiotic 2.398E-4 1.578E-3 1.006E-2
7.890E-2
 3 304
Show 45 more annotations

6: Domain [Display Chart] 6 input genes in category / 13 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 IPR000611 NPY rcpt InterPro 3.681E-13 4.786E-12 1.522E-11 4.786E-12 4 9
2 PD001267 Pancreatic hormone-like ProDom 2.564E-7 4.166E-7 1.325E-6 3.333E-6 2 3
3 PF00159 Hormone 3 Pfam 2.564E-7 4.166E-7 1.325E-6 3.333E-6 2 3
4 IPR001955 Pancreatic hormone-like InterPro 2.564E-7 4.166E-7 1.325E-6 3.333E-6 2 3
5 PS50276 PANCREATIC HORMONE 2 PROSITE 2.564E-7 4.166E-7 1.325E-6 3.333E-6 2 3
6 PS00265 PANCREATIC HORMONE 1 PROSITE 2.564E-7 4.166E-7 1.325E-6 3.333E-6 2 3
7 IPR020392 Pancreatic hormone-like CS InterPro 2.564E-7 4.166E-7 1.325E-6 3.333E-6 2 3
8 SM00309 PAH SMART 2.564E-7 4.166E-7 1.325E-6 3.333E-6 2 3
9 IPR000393 NPY5 rcpt InterPro 3.203E-4 3.785E-4 1.204E-3 4.163E-3 1 1
10 IPR000351 NPY1 rcpt InterPro 3.203E-4 3.785E-4 1.204E-3 4.163E-3 1 1
11 IPR001358 NPY2 rcpt InterPro 3.203E-4 3.785E-4 1.204E-3 4.163E-3 1 1
12 SM01381 7TM GPCR Srsx SMART 5.230E-4 5.666E-4 1.802E-3 6.800E-3 2 112
13 IPR001933 NPY4 rcpt InterPro 6.404E-4 6.404E-4 2.037E-3 8.326E-3 1 2
Show 8 more annotations

7: Pathway [Display Chart] 6 input genes in category / 12 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1269546 Peptide ligand-binding receptors BioSystems: REACTOME 1.095E-11 1.314E-10 4.078E-10 1.314E-10 6 188
2 1269576 G alpha (i) signalling events BioSystems: REACTOME 5.202E-11 3.121E-10 9.685E-10 6.242E-10 6 243
3 1269545 Class A/1 (Rhodopsin-like receptors) BioSystems: REACTOME 2.860E-10 1.144E-9 3.549E-9 3.431E-9 6 322
4 1269544 GPCR ligand binding BioSystems: REACTOME 2.308E-9 6.923E-9 2.148E-8 2.769E-8 6 455
5 83053 Neuroactive ligand-receptor interaction BioSystems: KEGG 3.523E-6 8.456E-6 2.624E-5 4.228E-5 4 278
6 1222950 Regulation of lipolysis in adipocytes BioSystems: KEGG 2.739E-4 5.478E-4 1.700E-3 3.287E-3 2 54
7 PW:0000448 neuropeptide Y metabolic Pathway Ontology 4.819E-4 8.262E-4 2.564E-3 5.783E-3 1 1
8 1017634 cAMP signaling pathway BioSystems: KEGG 3.619E-3 5.429E-3 1.685E-2 4.343E-2 2 198
9 PW:0000363 leptin system Pathway Ontology 5.770E-3 7.694E-3 2.388E-2
6.924E-2
 1 12
10 M7955 Genes related to the insulin receptor pathway MSigDB C2 BIOCARTA (v6.0) 2.433E-2 2.920E-2
9.061E-2
2.920E-1
 1 51
11 83093 Adipocytokine signaling pathway BioSystems: KEGG 3.280E-2 3.578E-2
1.110E-1
3.936E-1
 1 69
Show 6 more annotations

8: Pubmed [Display Chart] 6 input genes in category / 1113 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 10698177 Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Pubmed 8.862E-21 4.932E-18 3.744E-17 9.863E-18 5 5
2 12007534 Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Pubmed 8.862E-21 4.932E-18 3.744E-17 9.863E-18 5 5
3 17325259 Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men. Pubmed 5.317E-20 1.973E-17 1.498E-16 5.918E-17 5 6
4 17948870 Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Pubmed 1.692E-16 2.354E-14 1.787E-13 1.883E-13 4 4
5 19481128 Cloning and characterization of rabbit neuropeptide Y receptor subtypes. Pubmed 1.692E-16 2.354E-14 1.787E-13 1.883E-13 4 4
6 24985894 Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice. Pubmed 1.692E-16 2.354E-14 1.787E-13 1.883E-13 4 4
7 18828811 Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Pubmed 1.692E-16 2.354E-14 1.787E-13 1.883E-13 4 4
8 23011592 Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity. Pubmed 1.692E-16 2.354E-14 1.787E-13 1.883E-13 4 4
9 18577758 Dissociation of heterotrimeric g proteins in cells. Pubmed 9.741E-15 1.205E-12 9.146E-12 1.084E-11 6 179
10 2834384 Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs. Pubmed 1.527E-13 1.700E-11 1.291E-10 1.700E-10 5 75
11 16100526 The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
12 9722158 Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
13 19459152 NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
14 1321422 Cloned human neuropeptide Y receptor couples to two different second messenger systems. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
15 16198492 Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
16 11906964 Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
17 25471570 Actions of NPY, and its Y1 and Y2 receptors on pulsatile growth hormone secretion during the fed and fasted state. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
18 19759915 Variants in neuropeptide Y receptor 1 and 5 are associated with nutrient-specific food intake and are under recent selection in Europeans. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
19 11579129 Distinct roles of the Y1 and Y2 receptors on neuropeptide Y-induced sensitization to sedation. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
20 21452195 Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
21 22289084 NPY controls fear conditioning and fear extinction by combined action on Yâ?? and Yâ?? receptors. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
22 16891622 Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
23 12665544 The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
24 9001438 Neuropeptide Y receptor subtypes. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
25 10720571 Evolution of the neuropeptide Y receptor family: gene and chromosome duplications deduced from the cloning and mapping of the five receptor subtype genes in pig. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
26 7559383 Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. Pubmed 2.154E-12 9.221E-11 7.001E-10 2.398E-9 3 3
27 19058789 A common variant in DRD3 receptor is associated with autism spectrum disorder. Pubmed 2.433E-12 1.003E-10 7.613E-10 2.707E-9 5 129
28 7493937 Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. Pubmed 8.616E-12 3.307E-10 2.511E-9 9.589E-9 3 4
29 23395170 Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Pubmed 8.616E-12 3.307E-10 2.511E-9 9.589E-9 3 4
30 20468064 Association study of 182 candidate genes in anorexia nervosa. Pubmed 1.390E-11 5.156E-10 3.915E-9 1.547E-8 5 182
31 19593212 Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study. Pubmed 7.538E-11 2.706E-9 2.055E-8 8.389E-8 3 7
32 9417917 Neuropeptide Y receptor genes mapped in human and mouse: receptors with high affinity for pancreatic polypeptide are not clustered with receptors specific for neuropeptide Y and peptide YY. Pubmed 2.584E-10 8.987E-9 6.823E-8 2.876E-7 3 10
33 19874574 Genetical genomic determinants of alcohol consumption in rats and humans. Pubmed 1.912E-9 6.448E-8 4.896E-7 2.128E-6 4 130
34 14525913 Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
35 12084524 Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
36 21923762 NPY receptor subtype specification for behavioral adaptive strategies during limited food access. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
37 22768253 Y1 and Y5 receptors are both required for the regulation of food intake and energy homeostasis in mice. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
38 20471432 Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
39 23838112 Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
40 21745157 Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
41 12372697 Langerhans cell expression of neuropeptide Y and peptide YY. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
42 15331560 Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
43 27244241 Cell type specificity of neurovascular coupling in cerebral cortex. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
44 16190896 The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
45 25924821 Unwinding of the C-Terminal Residues of Neuropeptide Y is critical for Yâ?? Receptor Binding and Activation. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
46 19699258 Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
47 16339211 Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
48 23733357 Neuropeptide Y modulates fracture healing through Y1 receptor signaling. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
49 24121255 Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
50 14755515 Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus. Pubmed 2.057E-8 2.100E-7 1.594E-6 2.289E-5 2 2
Show 45 more annotations

9: Interaction [Display Chart] 6 input genes in category / 76 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:PYY PYY interactions 2.486E-18 1.889E-16 9.285E-16 1.889E-16 5 6
2 int:NPY NPY interactions 1.809E-15 6.874E-14 3.378E-13 1.375E-13 5 16
3 int:NPY5R NPY5R interactions 2.163E-10 3.287E-9 1.616E-8 1.644E-8 3 5
4 int:NPY4R NPY4R interactions 2.163E-10 3.287E-9 1.616E-8 1.644E-8 3 5
5 int:NPY1R NPY1R interactions 2.163E-10 3.287E-9 1.616E-8 1.644E-8 3 5
6 int:NPY2R NPY2R interactions 5.956E-7 7.545E-6 3.708E-5 4.527E-5 3 56
7 int:MEP1B MEP1B interactions 8.696E-6 9.441E-5 4.640E-4 6.609E-4 2 14
8 int:PPY PPY interactions 6.778E-4 6.439E-3 3.164E-2
5.151E-2
 1 2
9 int:NPFFR2 NPFFR2 interactions 1.355E-3 1.030E-2
5.061E-2
1.030E-1
 1 4
10 int:NT5C1A NT5C1A interactions 1.355E-3 1.030E-2
5.061E-2
1.030E-1
 1 4
11 int:SLC35F1 SLC35F1 interactions 1.694E-3 1.073E-2
5.272E-2
1.287E-1
 1 5
12 int:NPFF NPFF interactions 1.694E-3 1.073E-2
5.272E-2
1.287E-1
 1 5
13 int:PMCH PMCH interactions 3.723E-3 2.011E-2
9.883E-2
2.829E-1
 1 11
14 int:GHRL GHRL interactions 4.061E-3 2.011E-2
9.883E-2
3.086E-1
 1 12
15 int:MC4R MC4R interactions 4.399E-3 2.011E-2
9.883E-2
3.343E-1
 1 13
16 int:ORMDL2 ORMDL2 interactions 4.399E-3 2.011E-2
9.883E-2
3.343E-1
 1 13
17 int:FASTKD3 FASTKD3 interactions 5.074E-3 2.011E-2
9.883E-2
3.856E-1
 1 15
18 int:FASTKD1 FASTKD1 interactions 5.749E-3 2.011E-2
9.883E-2
4.369E-1
 1 17
19 int:MTFR2 MTFR2 interactions 5.749E-3 2.011E-2
9.883E-2
4.369E-1
 1 17
20 int:RTL8C RTL8C interactions 6.086E-3 2.011E-2
9.883E-2
4.625E-1
 1 18
21 int:SIMC1 SIMC1 interactions 6.423E-3 2.011E-2
9.883E-2
4.882E-1
 1 19
22 int:RGS12 RGS12 interactions 6.423E-3 2.011E-2
9.883E-2
4.882E-1
 1 19
23 int:DMXL2 DMXL2 interactions 6.760E-3 2.011E-2
9.883E-2
5.138E-1
 1 20
24 int:ARFGEF3 ARFGEF3 interactions 7.097E-3 2.011E-2
9.883E-2
5.394E-1
 1 21
25 int:FASTKD5 FASTKD5 interactions 7.097E-3 2.011E-2
9.883E-2
5.394E-1
 1 21
26 int:EVI5L EVI5L interactions 7.434E-3 2.011E-2
9.883E-2
5.650E-1
 1 22
27 int:RARS2 RARS2 interactions 7.434E-3 2.011E-2
9.883E-2
5.650E-1
 1 22
28 int:MEP1A MEP1A interactions 7.771E-3 2.011E-2
9.883E-2
5.906E-1
 1 23
29 int:ACAD10 ACAD10 interactions 7.771E-3 2.011E-2
9.883E-2
5.906E-1
 1 23
30 int:FDXR FDXR interactions 8.781E-3 2.011E-2
9.883E-2
6.674E-1
 1 26
31 int:ARFGEF1 ARFGEF1 interactions 8.781E-3 2.011E-2
9.883E-2
6.674E-1
 1 26
32 int:COQ5 COQ5 interactions 8.781E-3 2.011E-2
9.883E-2
6.674E-1
 1 26
33 int:MMS22L MMS22L interactions 9.117E-3 2.011E-2
9.883E-2
6.929E-1
 1 27
34 int:GPD2 GPD2 interactions 9.454E-3 2.011E-2
9.883E-2
7.185E-1
 1 28
35 int:NUPR1 NUPR1 interactions 9.454E-3 2.011E-2
9.883E-2
7.185E-1
 1 28
36 int:COG2 COG2 interactions 9.790E-3 2.011E-2
9.883E-2
7.440E-1
 1 29
37 int:NOCT NOCT interactions 9.790E-3 2.011E-2
9.883E-2
7.440E-1
 1 29
38 int:MZT2B MZT2B interactions 1.046E-2 2.092E-2
1.028E-1
7.951E-1
 1 31
39 int:SLC25A17 SLC25A17 interactions 1.080E-2 2.104E-2
1.034E-1
8.207E-1
 1 32
40 int:FLT4 FLT4 interactions 1.113E-2 2.115E-2
1.040E-1
8.462E-1
 1 33
41 int:RNF181 RNF181 interactions 1.147E-2 2.126E-2
1.045E-1
8.717E-1
 1 34
42 int:C16orf58 C16orf58 interactions 1.281E-2 2.213E-2
1.088E-1
9.737E-1
 1 38
43 int:ADCK1 ADCK1 interactions 1.281E-2 2.213E-2
1.088E-1
9.737E-1
 1 38
44 int:PAM16 PAM16 interactions 1.281E-2 2.213E-2
1.088E-1
9.737E-1
 1 38
45 int:IPO13 IPO13 interactions 1.315E-2 2.220E-2
1.091E-1
9.992E-1
 1 39
46 int:TRAPPC5 TRAPPC5 interactions 1.348E-2 2.228E-2
1.095E-1
1.000E0
 1 40
47 int:CAND2 CAND2 interactions 1.415E-2 2.289E-2
1.125E-1
1.000E0
 1 42
48 int:XPO6 XPO6 interactions 1.583E-2 2.369E-2
1.164E-1
1.000E0
 1 47
49 int:LSM7 LSM7 interactions 1.583E-2 2.369E-2
1.164E-1
1.000E0
 1 47
50 int:EXOC6 EXOC6 interactions 1.583E-2 2.369E-2
1.164E-1
1.000E0
 1 47
Show 45 more annotations

10: Cytoband [Display Chart] 6 input genes in category / 6 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 4q31.3-q32 4q31.3-q32 1.731E-4 1.039E-3 2.544E-3 1.039E-3 1 1
2 4q31-q32 4q31-q32 3.462E-4 1.039E-3 2.544E-3 2.077E-3 1 2
3 4q31 4q31 1.903E-3 3.373E-3 8.263E-3 1.142E-2 1 11
4 7p15.1 7p15.1 2.248E-3 3.373E-3 8.263E-3 1.349E-2 1 13
5 10q11.2 10q11.2 2.939E-3 3.527E-3 8.642E-3 1.764E-2 1 17
6 17q21.1 17q21.1 3.630E-3 3.630E-3 8.893E-3 2.178E-2 1 21
Show 1 more annotation

11: Transcription Factor Binding Site [Display Chart] 5 input genes in category / 19 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 6 input genes in category / 2 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 854 Neuropeptide receptors genenames.org 6.898E-13 1.380E-12 2.069E-12 1.380E-12 4 10
2 542 Endogenous ligands genenames.org 2.449E-3 2.449E-3 3.673E-3 4.897E-3 2 237

13: Coexpression [Display Chart] 6 input genes in category / 367 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M4985 Genes up-regulated in comparison of B cells from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination. MSigDB C7: Immunologic Signatures (v6.0) 1.211E-5 3.600E-3 2.334E-2 4.446E-3 3 198
2 15548687-table1 Human StemCell Staege04 38genes GeneSigDB 2.112E-5 3.600E-3 2.334E-2 7.751E-3 2 28
3 M10582 Genes up-regulated in Ewing family tumors (EFT) compared with normal bone marrow samples. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.949E-5 3.600E-3 2.334E-2 1.082E-2 2 33
4 M1962 Genes with intermediate-CpG-density promoters (ICP) bearing the bivalent tri-methylation marks at H3K4 (H3K4me3) and H3K27 (H3K27me3) in MEF cells (embryonic fibroblasts). MSigDB C2: CGP Curated Gene Sets (v6.0) 3.924E-5 3.600E-3 2.334E-2 1.440E-2 2 38
5 M1967 Genes with high-CpG-density promoters (HCP) bearing the tri-methylation mark at H3K27 (H3K27me3) in MCV8.1 (induced pluripotent cells, iPS). MSigDB C2: CGP Curated Gene Sets (v6.0) 2.854E-4 2.095E-2
1.358E-1
1.047E-1
 2 102
6 M6767 Genes down-regulated in atypical ductal hyperplastic tissues from patients with (ADHC) breast cancer vs those without the cancer (ADH). MSigDB C2: CGP Curated Gene Sets (v6.0) 4.919E-4 2.695E-2
1.747E-1
1.805E-1
 2 134
7 M2005 Genes with intermediate-CpG-density promoters (ICP) bearing bivalent histone H3 methylation mark (H3K4me3 and H3K27me3) in embryonic stem cells (ES). MSigDB C2: CGP Curated Gene Sets (v6.0) 5.140E-4 2.695E-2
1.747E-1
1.886E-1
 2 137
8 M18058 Genes up-regulated in primary cultures of ovarian surface epithlium cells exposed to progesterone [PubChem=5994] for 5 days. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.321E-4 2.900E-2
1.880E-1
2.320E-1
 2 152
9 M2741 Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of SUZ12 [Gene ID=23512] gene. MSigDB C6: Oncogenic Signatures (v6.0) 1.016E-3 3.637E-2
2.358E-1
3.728E-1
 2 193
10 M9910 Genes down-regulated in dendritic cells: untreated versus 8h after infection of Leishmania major. MSigDB C7: Immunologic Signatures (v6.0) 1.058E-3 3.637E-2
2.358E-1
3.882E-1
 2 197
11 M9610 Genes up-regulated in T reg: peripheral lymph nodes versus thymic CD24 high [GeneID=100133941]. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 3.637E-2
2.358E-1
4.001E-1
 2 200
12 M1219 Genes down-regulated in the erbb2 subype of breast cancer samples, characterized by higher expression of ERBB2 [GeneID=2064]. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.296E-3 3.964E-2
2.570E-1
4.757E-1
 1 5
13 19286929-SuppTable2n Mouse Lung Rangasamy09 254genes GeneSigDB 1.551E-3 4.378E-2
2.839E-1
5.692E-1
 2 239
14 M828 Genes down-regulated in breast cancer tumors (formed by MCF-7 xenografts) resistant to tamoxifen [PubChem=5376]. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.790E-3 4.493E-2
2.913E-1
6.570E-1
 2 257
15 18310505-TableS8 Human StemCell Matushansky08 297genes GeneSigDB 1.959E-3 4.493E-2
2.913E-1
7.189E-1
 2 269
16 M1938 Genes with high-CpG-density promoters (HCP) bearing the H3K27 tri-methylation (H3K27me3) mark in brain. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.959E-3 4.493E-2
2.913E-1
7.189E-1
 2 269
17 M14791 Genes down-regulated in colorectal adenoma compared to normal mucosa samples. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.287E-3 4.504E-2
2.921E-1
8.394E-1
 2 291
18 18794137-SuppTable1d Human Breast Creighton08 453genes GeneSigDB 2.318E-3 4.504E-2
2.921E-1
8.508E-1
 2 293
19 M1663 Genes up-regulated in rFSH-17 cells (primary granulosa) after stimulation with FSH. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.332E-3 4.504E-2
2.921E-1
8.558E-1
 1 9
20 M6386 The 'group 4 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 but not ERBB2 [GeneID=2099;2064]. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.509E-3 4.528E-2
2.936E-1
9.207E-1
 2 305
21 M6706 Top genes down-regulated in colon epithelium biopsies from FAP (familial adenomatous polyposis) patients with mutated APC [GeneID=324]. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.591E-3 4.528E-2
2.936E-1
9.508E-1
 1 10
Show 16 more annotations

14: Coexpression Atlas [Display Chart] 6 input genes in category / 369 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 BrainMap BrainAtlas - Mouse McCarroll Neuron.inhibitory.Gad1,Gad2 Neuron.inhibitory.Gad1,Gad2 Subtype Neuron.inhibitory.Gad1,Gad2.Synpr,Pcdh11x Top 200 Genes BrainMap BrainAtlas - Mouse McCarroll Neuron.inhibitory.Gad1,Gad2 Neuron.inhibitory.Gad1,Gad2 Subtype Neuron.inhibitory.Gad1,Gad2.Synpr,Pcdh11x Top 200 Genes BrainMap 8.765E-7 1.733E-4 1.125E-3 3.234E-4 4 343
2 BrainMap BrainAtlas - Mouse McCarroll Neuron.inhibitory.Gad1,Gad2 Neuron.inhibitory.Gad1,Gad2 Subtype Neuron.inhibitory.Gad1,Gad2.Synpr,Slc5a7,Chat Top 200 Genes BrainMap BrainAtlas - Mouse McCarroll Neuron.inhibitory.Gad1,Gad2 Neuron.inhibitory.Gad1,Gad2 Subtype Neuron.inhibitory.Gad1,Gad2.Synpr,Slc5a7,Chat Top 200 Genes BrainMap 9.394E-7 1.733E-4 1.125E-3 3.466E-4 4 349
3 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Chat BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Chat BrainMap 1.214E-5 1.493E-3 9.691E-3 4.480E-3 3 187
4 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup5/Prlr BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup5/Prlr BrainMap 6.109E-4 3.293E-2
2.137E-1
2.254E-1
 2 141
5 colon colon Human Protein Atlas 7.758E-4 3.293E-2
2.137E-1
2.863E-1
 2 159
6 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Microglia/Microglia/Microglia/C1qb//Tmem119/Microglia.C1qb.Tmem119/FrontalCortex BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Microglia/Microglia/Microglia/C1qb//Tmem119/Microglia.C1qb.Tmem119/FrontalCortex BrainMap 8.451E-4 3.293E-2
2.137E-1
3.119E-1
 2 166
7 rectum rectum Human Protein Atlas 8.655E-4 3.293E-2
2.137E-1
3.194E-1
 2 168
8 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Ecel1 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Ecel1 BrainMap 9.068E-4 3.293E-2
2.137E-1
3.346E-1
 2 172
9 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup5/Chodl BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup5/Chodl BrainMap 9.279E-4 3.293E-2
2.137E-1
3.424E-1
 2 174
10 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Krt73 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Krt73 BrainMap 9.492E-4 3.293E-2
2.137E-1
3.502E-1
 2 176
11 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Slc17a8 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup2/Slc17a8 BrainMap 9.815E-4 3.293E-2
2.137E-1
3.622E-1
 2 179
12 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Endothelial Stalk/Endothelial Stalk/Endothelial Stalk/Flt1//Gkn3/Endothelial Stalk.Flt1.Gkn3/FrontalCortex BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Endothelial Stalk/Endothelial Stalk/Endothelial Stalk/Flt1//Gkn3/Endothelial Stalk.Flt1.Gkn3/FrontalCortex BrainMap 1.105E-3 3.397E-2
2.205E-1
4.077E-1
 2 190
Show 7 more annotations

15: Computational [Display Chart] 5 input genes in category / 27 annotations before applied cutoff / 10037 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M6672 MODULE 146 Genes in the cancer module 146. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.004E-5 2.440E-4 9.496E-4 2.711E-4 3 102
2 M12584 MODULE 289 Genes in the cancer module 289. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.808E-5 2.440E-4 9.496E-4 4.881E-4 3 124
3 M3544 MODULE 134 Genes in the cancer module 134. MSigDb: C4 - CM: Cancer Modules (v6.0) 8.589E-5 7.730E-4 3.008E-3 2.319E-3 2 30
4 M491 MODULE 288 Genes in the cancer module 288. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.313E-4 8.864E-4 3.449E-3 3.545E-3 2 37
5 M688 MODULE 27 Genes in the cancer module 27. MSigDb: C4 - CM: Cancer Modules (v6.0) 4.161E-4 2.247E-3 8.744E-3 1.123E-2 3 355
6 M15983 MODULE 46 Genes in the cancer module 46. MSigDb: C4 - CM: Cancer Modules (v6.0) 5.659E-4 2.249E-3 8.751E-3 1.528E-2 3 394
7 M12401 MODULE 75 Immune response. MSigDb: C4 - CM: Cancer Modules (v6.0) 5.830E-4 2.249E-3 8.751E-3 1.574E-2 3 398
8 M19754 MODULE 375 GPCR signaling pathways (immune and neuro). MSigDb: C4 - CM: Cancer Modules (v6.0) 7.813E-4 2.637E-3 1.026E-2 2.110E-2 2 90
9 M9347 MODULE 176 Signaling. MSigDb: C4 - CM: Cancer Modules (v6.0) 4.995E-3 1.499E-2
5.832E-2
1.349E-1
 2 230
10 M16447 MODULE 112 Genes in the cancer module 112. MSigDb: C4 - CM: Cancer Modules (v6.0) 6.348E-3 1.714E-2
6.670E-2
1.714E-1
 2 260
11 M17631 MODULE 382 Peptide hormones. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.387E-2 3.405E-2
1.325E-1
3.746E-1
 1 28
Show 6 more annotations

16: MicroRNA [Display Chart] 6 input genes in category / 80 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-302f:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.462E-4 1.170E-2
5.809E-2
 1.170E-2 2 227
2 hsa-miR-4497:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.483E-3 3.995E-2
1.984E-1
2.787E-1
 1 42
3 hsa-miR-6874-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.980E-3 3.995E-2
1.984E-1
3.184E-1
 1 48
4 hsa-miR-148b-5p:Functional MTI Functional MTI miRTarbase 4.311E-3 3.995E-2
1.984E-1
3.449E-1
 1 52
5 hsa-miR-1280:mirSVR highEffct hsa-miR-1280:mirSVR nonconserved highEffect-0.5 MicroRNA.org 4.725E-3 3.995E-2
1.984E-1
3.780E-1
 1 57
6 hsa-miR-103b:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.056E-3 3.995E-2
1.984E-1
4.045E-1
 1 61
7 hsa-miR-1249:mirSVR highEffct hsa-miR-1249:mirSVR nonconserved highEffect-0.5 MicroRNA.org 5.469E-3 3.995E-2
1.984E-1
4.375E-1
 1 66
8 hsa-miR-3614-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.469E-3 3.995E-2
1.984E-1
4.375E-1
 1 66
9 hsa-miR-1539:mirSVR highEffct hsa-miR-1539:mirSVR nonconserved highEffect-0.5 MicroRNA.org 5.800E-3 3.995E-2
1.984E-1
4.640E-1
 1 70
10 hsa-miR-4499:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.791E-3 3.995E-2
1.984E-1
5.433E-1
 1 82
11 CAATGCA,MIR-33:MSigDB CAATGCA,MIR-33:MSigDB MSigDB 7.452E-3 3.995E-2
1.984E-1
5.962E-1
 1 90
12 hsa-miR-4803:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.700E-3 3.995E-2
1.984E-1
6.160E-1
 1 93
13 hsa-miR-100-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.102E-3 3.995E-2
1.984E-1
7.281E-1
 1 110
14 hsa-miR-6857-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.184E-3 3.995E-2
1.984E-1
7.347E-1
 1 111
15 hsa-miR-1184:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.184E-3 3.995E-2
1.984E-1
7.347E-1
 1 111
16 hsa-miR-6844:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.184E-3 3.995E-2
1.984E-1
7.347E-1
 1 111
17 hsa-miR-105*:mirSVR highEffct hsa-miR-105*:mirSVR nonconserved highEffect-0.5 MicroRNA.org 9.596E-3 3.995E-2
1.984E-1
7.677E-1
 1 116
18 hsa-miR-1268:mirSVR highEffct hsa-miR-1268:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.100E-2 3.995E-2
1.984E-1
8.797E-1
 1 133
19 hsa-miR-7156-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.133E-2 3.995E-2
1.984E-1
9.060E-1
 1 137
20 hsa-miR-4325:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.272E-2 3.995E-2
1.984E-1
1.000E0
 1 154
21 hsa-miR-873-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.313E-2 3.995E-2
1.984E-1
1.000E0
 1 159
22 hsa-miR-298:Functional MTI Functional MTI miRTarbase 1.363E-2 3.995E-2
1.984E-1
1.000E0
 1 165
23 hsa-miR-375:mirSVR highEffct hsa-miR-375:mirSVR conserved highEffect-0.5 MicroRNA.org 1.404E-2 3.995E-2
1.984E-1
1.000E0
 1 170
24 hsa-miR-208a:mirSVR highEffct hsa-miR-208a:mirSVR conserved highEffect-0.5 MicroRNA.org 1.478E-2 3.995E-2
1.984E-1
1.000E0
 1 179
25 hsa-miR-636:PITA hsa-miR-636:PITA TOP PITA 1.494E-2 3.995E-2
1.984E-1
1.000E0
 1 181
26 hsa-miR-208b:mirSVR highEffct hsa-miR-208b:mirSVR conserved highEffect-0.5 MicroRNA.org 1.560E-2 3.995E-2
1.984E-1
1.000E0
 1 189
27 ACTGAAA,MIR-30A-3P:MSigDB ACTGAAA,MIR-30A-3P:MSigDB MSigDB 1.560E-2 3.995E-2
1.984E-1
1.000E0
 1 189
28 ACTGAAA,MIR-30E-3P:MSigDB ACTGAAA,MIR-30E-3P:MSigDB MSigDB 1.560E-2 3.995E-2
1.984E-1
1.000E0
 1 189
29 hsa-miR-219b-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.691E-2 3.995E-2
1.984E-1
1.000E0
 1 205
30 hsa-miR-33a:PITA hsa-miR-33a:PITA TOP PITA 1.895E-2 3.995E-2
1.984E-1
1.000E0
 1 230
31 hsa-miR-33b:PITA hsa-miR-33b:PITA TOP PITA 1.903E-2 3.995E-2
1.984E-1
1.000E0
 1 231
32 ATGTTAA,MIR-302C:MSigDB ATGTTAA,MIR-302C:MSigDB MSigDB 1.912E-2 3.995E-2
1.984E-1
1.000E0
 1 232
33 hsa-miR-6721-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.944E-2 3.995E-2
1.984E-1
1.000E0
 1 236
34 hsa-miR-3187-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.099E-2 3.995E-2
1.984E-1
1.000E0
 1 255
35 hsa-miR-5189-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.116E-2 3.995E-2
1.984E-1
1.000E0
 1 257
36 hsa-miR-612:Non-Functional MTI Non-Functional MTI miRTarbase 2.124E-2 3.995E-2
1.984E-1
1.000E0
 1 258
37 hsa-miR-6860:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.124E-2 3.995E-2
1.984E-1
1.000E0
 1 258
38 hsa-miR-1285-3p:Functional MTI Functional MTI miRTarbase 2.132E-2 3.995E-2
1.984E-1
1.000E0
 1 259
39 hsa-miR-873-5p.1:TargetScan hsa-miR-873-5p.1 TargetScan 2.189E-2 3.995E-2
1.984E-1
1.000E0
 1 266
40 hsa-miR-107:Functional MTI Functional MTI miRTarbase 2.466E-2 3.995E-2
1.984E-1
1.000E0
 1 300
41 hsa-miR-4747-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.507E-2 3.995E-2
1.984E-1
1.000E0
 1 305
42 hsa-miR-5196-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.507E-2 3.995E-2
1.984E-1
1.000E0
 1 305
43 hsa-miR-1249:mirSVR lowEffct hsa-miR-1249:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 2.580E-2 3.995E-2
1.984E-1
1.000E0
 1 314
44 hsa-miR-718:mirSVR lowEffct hsa-miR-718:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 2.596E-2 3.995E-2
1.984E-1
1.000E0
 1 316
45 hsa-miR-367-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.718E-2 3.995E-2
1.984E-1
1.000E0
 1 331
46 hsa-miR-363-3p:Functional MTI Functional MTI miRTarbase 2.807E-2 3.995E-2
1.984E-1
1.000E0
 1 342
47 hsa-miR-9-5p:Functional MTI Functional MTI miRTarbase 2.872E-2 3.995E-2
1.984E-1
1.000E0
 1 350
48 hsa-miR-886-5p:mirSVR lowEffct hsa-miR-886-5p:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 2.961E-2 3.995E-2
1.984E-1
1.000E0
 1 361
49 hsa-miR-3913-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.026E-2 3.995E-2
1.984E-1
1.000E0
 1 369
50 hsa-miR-3122:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.034E-2 3.995E-2
1.984E-1
1.000E0
 1 370
Show 45 more annotations

17: Drug [Display Chart] 6 input genes in category / 1604 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID005312150 SR 120107A Stitch 2.433E-18 3.902E-15 3.105E-14 3.902E-15 5 7
2 CID005312114 CGP71683A Stitch 5.352E-17 4.292E-14 3.416E-13 8.584E-14 5 11
3 CID005311021 BIBO3304 Stitch 1.347E-15 7.200E-13 5.729E-12 2.160E-12 5 19
4 CID003260015 AC1MMF4Q Stitch 4.921E-15 1.973E-12 1.570E-11 7.894E-12 5 24
5 CID000002339 AC1L1DGI Stitch 4.629E-14 1.485E-11 1.182E-10 7.426E-11 4 7
6 CID005311023 BIBP3226 Stitch 1.256E-13 3.359E-11 2.673E-10 2.015E-10 5 44
7 CID003311407 AC1MNXPB Stitch 9.453E-13 2.166E-10 1.724E-9 1.516E-9 4 13
8 CID000123797 Neuropeptide Ff Stitch 1.299E-12 2.605E-10 2.073E-9 2.084E-9 5 69
9 CID000126014 AC1O5Q3P Stitch 1.007E-11 1.469E-9 1.169E-8 1.615E-8 3 3
10 ctd:C403256 BIIE 0246 CTD 1.007E-11 1.469E-9 1.169E-8 1.615E-8 3 3
11 CID000459719 8-acetamido-6-chloro-5-nitroquinoline Stitch 1.007E-11 1.469E-9 1.169E-8 1.615E-8 3 3
12 CID005311024 BIIE0246 Stitch 1.404E-11 1.876E-9 1.493E-8 2.252E-8 4 24
13 ctd:D015544 Inositol 1,4,5-Trisphosphate CTD 1.671E-11 2.062E-9 1.641E-8 2.680E-8 4 25
14 CID000447966 Py-1 Stitch 2.318E-11 2.656E-9 2.113E-8 3.718E-8 4 27
15 CID000002317 benextramine Stitch 4.748E-11 5.077E-9 4.040E-8 7.616E-8 4 32
16 CID000465968 KRH-1636 Stitch 1.966E-10 1.970E-8 1.568E-7 3.153E-7 4 45
17 CID005388938 Py-3 Stitch 8.455E-10 7.534E-8 5.996E-7 1.356E-6 3 9
18 CID000125845 Tmd)Phe Stitch 8.455E-10 7.534E-8 5.996E-7 1.356E-6 3 9
19 CID000004425 EN-1530 Stitch 1.531E-9 1.292E-7 1.028E-6 2.455E-6 5 278
20 CID003342293 AC1MOE8Y Stitch 1.877E-9 1.506E-7 1.198E-6 3.011E-6 4 78
21 CID000066085 8a-c Stitch 2.878E-9 2.198E-7 1.749E-6 4.616E-6 3 13
22 CID000449625 AC1L9NBR Stitch 3.674E-9 2.679E-7 2.132E-6 5.893E-6 4 92
23 CID000036511 Substance P Stitch 4.397E-9 3.066E-7 2.440E-6 7.052E-6 5 343
24 CID000068740 zoledronic acid Stitch 7.038E-9 4.704E-7 3.743E-6 1.129E-5 4 108
25 CID000002443 alpha-bromoergocriptine Stitch 2.127E-8 1.365E-6 1.086E-5 3.412E-5 4 142
26 CID000161645 oriens Stitch 2.950E-8 1.820E-6 1.448E-5 4.732E-5 4 154
27 ctd:C079216 PYX 2 CTD 5.751E-8 3.294E-6 2.621E-5 9.224E-5 2 2
28 ctd:C059889 neuropeptide Y (18-36) CTD 5.751E-8 3.294E-6 2.621E-5 9.224E-5 2 2
29 CID000449606 AC1L9NAZ Stitch 8.107E-8 4.484E-6 3.568E-5 1.300E-4 4 198
30 CID000444980 LY178550 Stitch 9.172E-8 4.904E-6 3.902E-5 1.471E-4 3 39
31 CID000005210 sibutramine Stitch 9.914E-8 4.970E-6 3.955E-5 1.590E-4 3 40
32 CID000013591 N-nitrosopyrrolidine Stitch 9.914E-8 4.970E-6 3.955E-5 1.590E-4 3 40
33 CID000232997 2-naphthalenesulfonamide Stitch 1.725E-7 7.905E-6 6.291E-5 2.767E-4 2 3
34 CID000461371 Hamacanthine A Stitch 1.725E-7 7.905E-6 6.291E-5 2.767E-4 2 3
35 CID000069684 cyclohexylurea Stitch 1.725E-7 7.905E-6 6.291E-5 2.767E-4 2 3
36 CID000023992 ytterbium Stitch 2.629E-7 1.171E-5 9.321E-5 4.216E-4 3 55
37 CID000031275 dioxane Stitch 3.160E-7 1.370E-5 1.090E-4 5.069E-4 4 278
38 CID011840944 Fro Stitch 3.256E-7 1.374E-5 1.094E-4 5.223E-4 3 59
39 CID000012725 isopropylurea Stitch 5.749E-7 2.364E-5 1.881E-4 9.221E-4 2 5
40 CID000468793 AC1LAHXK Stitch 7.314E-7 2.933E-5 2.334E-4 1.173E-3 3 77
41 CID000673681 2-mercaptonicotinic acid Stitch 8.622E-7 3.373E-5 2.684E-4 1.383E-3 2 6
42 CID000004599 Orlistat, 5 Stitch 1.022E-6 3.904E-5 3.107E-4 1.640E-3 3 86
43 CID000452611 pGlu-His-Pro-NH2 Stitch 1.207E-6 4.422E-5 3.519E-4 1.936E-3 2 7
44 CID000000979 p-hydroxyphenylpyruvate Stitch 1.213E-6 4.422E-5 3.519E-4 1.946E-3 3 91
45 ctd:D013549 Sweetening Agents CTD 1.609E-6 5.735E-5 4.564E-4 2.581E-3 2 8
46 CID000003816 NSC759587 Stitch 2.049E-6 7.059E-5 5.618E-4 3.286E-3 4 444
47 ctd:C062527 tribromoethanol CTD 2.069E-6 7.059E-5 5.618E-4 3.318E-3 2 9
48 CID000447364 3-nitro-4-hydroxyphenylacetic acid Stitch 2.333E-6 7.795E-5 6.203E-4 3.742E-3 3 113
49 CID000131252 Bd 737 Stitch 2.585E-6 8.294E-5 6.600E-4 4.147E-3 2 10
50 CID000001208 normetazocine Stitch 2.585E-6 8.294E-5 6.600E-4 4.147E-3 2 10
Show 45 more annotations

18: Disease [Display Chart] 6 input genes in category / 142 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C0236663 Alcohol withdrawal syndrome DisGeNET Curated 4.756E-10 6.753E-8 3.739E-7 6.753E-8 4 40
2 C0003123 Anorexia DisGeNET Curated 4.499E-6 2.071E-4 1.147E-3 6.389E-4 3 100
3 C0001973 Alcoholic Intoxication, Chronic DisGeNET Curated 5.381E-6 2.071E-4 1.147E-3 7.640E-4 4 402
4 C0028756 Obesity, Morbid DisGeNET Curated 5.834E-6 2.071E-4 1.147E-3 8.285E-4 3 109
5 C0014556 Epilepsy, Temporal Lobe DisGeNET Curated 1.038E-5 2.948E-4 1.632E-3 1.474E-3 3 132
6 C0020175 Hunger DisGeNET BeFree 2.630E-5 6.225E-4 3.447E-3 3.735E-3 2 22
7 C0038587 Substance Withdrawal Syndrome DisGeNET Curated 1.807E-4 3.026E-3 1.676E-2 2.566E-2 2 57
8 C0752166 Bardet-Biedl Syndrome DisGeNET Curated 1.871E-4 3.026E-3 1.676E-2 2.657E-2 2 58
9 C0003469 Anxiety Disorders DisGeNET Curated 2.465E-4 3.026E-3 1.676E-2 3.501E-2 3 382
10 C0600427 Cocaine Dependence DisGeNET Curated 2.499E-4 3.026E-3 1.676E-2 3.549E-2 2 67
11 C2362324 Pediatric Obesity DisGeNET Curated 2.728E-4 3.026E-3 1.676E-2 3.874E-2 2 70
12 C1868649 PANIC DISORDER 1 DisGeNET BeFree 3.302E-4 3.026E-3 1.676E-2 4.689E-2 2 77
13 C0085762 Alcohol abuse DisGeNET Curated 3.388E-4 3.026E-3 1.676E-2 4.811E-2 2 78
14 C0155601 Hypertensive heart and renal disease DisGeNET BeFree 3.703E-4 3.026E-3 1.676E-2
5.258E-2
 1 1
15 C0334526 Strumal carcinoid DisGeNET BeFree 3.703E-4 3.026E-3 1.676E-2
5.258E-2
 1 1
16 C0040460 Toothache DisGeNET Curated 3.703E-4 3.026E-3 1.676E-2
5.258E-2
 1 1
17 C0853892 Catabolic state DisGeNET BeFree 3.703E-4 3.026E-3 1.676E-2
5.258E-2
 1 1
18 C0030319 Panic Disorder DisGeNET Curated 3.836E-4 3.026E-3 1.676E-2
5.448E-2
 2 83
19 C0236736 Cocaine-Related Disorders DisGeNET Curated 6.487E-4 4.848E-3 2.684E-2
9.211E-2
 2 108
20 C0423732 After pains DisGeNET BeFree 7.404E-4 5.007E-3 2.772E-2
1.051E-1
 1 2
21 C0743244 Chronic drug abuse DisGeNET BeFree 7.404E-4 5.007E-3 2.772E-2
1.051E-1
 1 2
22 C0027429 Nasal obstruction present finding DisGeNET Curated 1.110E-3 6.856E-3 3.796E-2
1.577E-1
 1 3
23 C0474822 Benign pheochromocytoma DisGeNET BeFree 1.110E-3 6.856E-3 3.796E-2
1.577E-1
 1 3
24 C0027794 Neural Tube Defects DisGeNET Curated 1.381E-3 8.171E-3 4.524E-2
1.961E-1
 2 158
25 C1334804 Motor Manifestations DisGeNET BeFree 1.480E-3 8.408E-3 4.655E-2
2.102E-1
 1 4
26 C0149721 Left Ventricular Hypertrophy DisGeNET Curated 1.768E-3 9.654E-3
5.345E-2
2.510E-1
 2 179
27 C0236664 Alcohol-Related Disorders DisGeNET Curated 2.220E-3 1.051E-2
5.817E-2
3.152E-1
 1 6
28 C0086768 Pancreatic Cholera DisGeNET BeFree 2.220E-3 1.051E-2
5.817E-2
3.152E-1
 1 6
29 C0588006 Mild depression DisGeNET Curated 2.220E-3 1.051E-2
5.817E-2
3.152E-1
 1 6
30 C0751230 Hypothalamic Dysfunction Syndromes DisGeNET BeFree 2.220E-3 1.051E-2
5.817E-2
3.152E-1
 1 6
31 C0242339 Dyslipidemias DisGeNET Curated 2.377E-3 1.089E-2
6.029E-2
3.376E-1
 2 208
32 C0349204 Nonorganic psychosis DisGeNET Curated 2.679E-3 1.189E-2
6.581E-2
3.804E-1
 2 221
33 C0085625 Hypoalgesia DisGeNET BeFree 2.959E-3 1.192E-2
6.601E-2
4.202E-1
 1 8
34 C0748607 Recurrent seizures DisGeNET BeFree 2.959E-3 1.192E-2
6.601E-2
4.202E-1
 1 8
35 C1168328 Low Grade Prostatic Intraepithelial Neoplasia DisGeNET BeFree 2.959E-3 1.192E-2
6.601E-2
4.202E-1
 1 8
36 C1292778 Chronic myeloproliferative disorder DisGeNET BeFree 3.023E-3 1.192E-2
6.601E-2
4.292E-1
 2 235
37 C2362914 clinical depression DisGeNET Curated 3.328E-3 1.277E-2
7.072E-2
4.726E-1
 1 9
38 C0338106 Adenocarcinoma of colon DisGeNET BeFree 3.686E-3 1.378E-2
7.627E-2
5.235E-1
 2 260
39 C1839130 Dystonia 3, Torsion, X-Linked DisGeNET Curated 4.067E-3 1.481E-2
8.198E-2
5.774E-1
 1 11
40 C0033975 Psychotic Disorders DisGeNET Curated 5.233E-3 1.786E-2
9.887E-2
7.431E-1
 2 311
41 C0525045 Mood Disorders DisGeNET Curated 5.299E-3 1.786E-2
9.887E-2
7.525E-1
 2 313
42 C1096903 Sialic Acid Storage Disease, Finnish Type (disorder) DisGeNET Curated 5.542E-3 1.786E-2
9.887E-2
7.869E-1
 1 15
43 C4025886 Severe periodontitis DisGeNET Curated 5.542E-3 1.786E-2
9.887E-2
7.869E-1
 1 15
44 C0020459 Hyperinsulinism DisGeNET Curated 5.771E-3 1.786E-2
9.887E-2
8.195E-1
 2 327
45 C0035309 Retinal Diseases DisGeNET Curated 5.875E-3 1.786E-2
9.887E-2
8.342E-1
 2 330
46 cv:C0028754 Obesity Clinical Variations 5.910E-3 1.786E-2
9.887E-2
8.393E-1
 1 16
47 C0001957 Alcohol Withdrawal Delirium DisGeNET Curated 5.910E-3 1.786E-2
9.887E-2
8.393E-1
 1 16
48 C0033941 Psychoses, Substance-Induced DisGeNET Curated 6.279E-3 1.820E-2
1.007E-1
8.916E-1
 1 17
49 C0020564 Hypertrophy DisGeNET Curated 6.279E-3 1.820E-2
1.007E-1
8.916E-1
 1 17
50 C0001818 Agoraphobia DisGeNET Curated 6.647E-3 1.888E-2
1.045E-1
9.439E-1
 1 18
Show 45 more annotations